Recent Company News
Emergent BioSolutions and the European Corporate Security Association...Jun 05, 2008
Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine...Jun 05, 2008  
Emergent BioSolutions to Webcast Presentation at the Jefferies and Company...Jun 04, 2008   
Emergent BioSolutions to Acquire Protein Sciences' Phase III Recombinant...May 27, 2008  
Emergent BioSolutions Reports Financial Results for First Quarter 2008May 07, 2008  
Emergent BioSolutions Acquires Advanced Recombinant Protective Antigen...May 05, 2008  
Archive

Video Library

Corporate Media Contacts

Media Relations
Ms. Tracey Schmitt
E-mail: schmittt@ebsi.com
Tel: 301-795-1800
Fax: 301-795-1899

Investor Relations
Mr. Robert Burrows
E-mail:burrowsr@ebsi.com
Tel: 301-795-1877
Fax: 301-795-1899